Page last updated: 2024-11-06

thyroxine and Triple Negative Breast Neoplasms

thyroxine has been researched along with Triple Negative Breast Neoplasms in 1 studies

Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.

Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nisman, B1
Allweis, TM1
Carmon, E1
Kadouri, L1
Maly, B1
Maimon, O1
Meirovitz, A1
Peretz, T1

Other Studies

1 other study available for thyroxine and Triple Negative Breast Neoplasms

ArticleYear
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast Cancer.
    Anticancer research, 2021, Volume: 41, Issue:2

    Topics: Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Thymidine K

2021